These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 696468)

  • 1. Regulation of GABA release by dopamine in the rat substantia nigra.
    Reubi JC; Iversen LL; Jessell TM
    Adv Biochem Psychopharmacol; 1978; 19():401-4. PubMed ID: 696468
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of substance P release from the isolated rat substantia nigra by GABA [proceedings].
    Jessell TM; Iversen LL
    Br J Pharmacol; 1977 Mar; 59(3):486P. PubMed ID: 843724
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of GABA release by dopamine in the substantia nigra.
    Matuszewich L; Yamamoto BK
    Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro.
    Reubi JC; Iversen LL; Jessell TM
    Nature; 1977 Aug; 268(5621):652-4. PubMed ID: 197423
    [No Abstract]   [Full Text] [Related]  

  • 6. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dopamine agonists on gamma-aminobutyric acid (GABA) turnover in the superior colliculus: evidence that nigrotectal GABA projections are under the influence of dopaminergic transmission.
    Melis MR; Gale K
    J Pharmacol Exp Ther; 1983 Aug; 226(2):425-31. PubMed ID: 6875856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic and opposite effects of dopamine and apomorphine on endogenous GABA release in the rat substantia nigra.
    van der Heyden JA; Venema K; Korf J
    J Neurochem; 1980 Jan; 34(1):119-25. PubMed ID: 6778956
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution and release of GABA in the basal ganglia.
    Korf J; van der Heyden JA; Venema K; Postema F
    Adv Biochem Psychopharmacol; 1981; 30():105-17. PubMed ID: 7331934
    [No Abstract]   [Full Text] [Related]  

  • 11. 6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.
    Rangel-Barajas C; Silva I; García-Ramírez M; Sánchez-Lemus E; Floran L; Aceves J; Erlij D; Florán B
    Neuropharmacology; 2008 Oct; 55(5):704-11. PubMed ID: 18588904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide co-release with GABA may explain functional non-monotonic uncertainty responses in dopamine neurons.
    Tan CO; Bullock D
    Neurosci Lett; 2008 Jan; 430(3):218-23. PubMed ID: 18053647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-tubocurarine reduces GABA responses in rat substantia nigra dopamine neurons.
    Caputi L; Bengtson CP; Guatteo E; Bernardi G; Mercuri NB
    Synapse; 2003 Mar; 47(3):236-9. PubMed ID: 12494406
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of ethanol on the motor activity of rats and on the content of GABA and dopamine and its metabolites in the nigrostriatal system].
    Karpova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(5):1027-30. PubMed ID: 1336265
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro.
    Reubi JC; Emson PC; Jessell TM; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):271-5. PubMed ID: 714184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioural effects of EOS-induced changes in substantia nigra GABA levels [proceedings].
    Koob G; del Fiacco M; Iversen SD
    Br J Pharmacol; 1976 Nov; 58(3):454P. PubMed ID: 990632
    [No Abstract]   [Full Text] [Related]  

  • 18. Synaptosomal uptake and release of dopamine in substantia nigra: effects of gamma-aminobutyric acid and substance P.
    Silbergeld EK; Walters JR
    Neurosci Lett; 1979 Apr; 12(1):119-26. PubMed ID: 460694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the regulation of gamma-aminobutyric acid neurons in caudatus, pallidus and nigra: effects of opioids and dopamine agonists.
    Moroni F; Peralta E; Cheney DL; Costa E
    J Pharmacol Exp Ther; 1979 Feb; 208(2):190-4. PubMed ID: 762651
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.